Drug information provided by: Merative, Micromedex®
Fidanacogene elaparvovec-dzkt injection is used to treat moderate to severe hemophilia B (congenital Factor IX deficiency) in patients who are using Factor IX treatment, have current or history of life-threatening bleeding, have repeated serious bleeding episodes, or who do not have antibodies to adeno-associated virus serotype Rh74var (AAVRh74var) capsid.
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: July 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.